HKU ResearcherPage:
Yuen, RMF
Co-Investigator
|
|
Project Code |
Amount |
Title |
Funding Year |
| 1 |
|
08090791
|
682630 |
Perceptions of cancer risk and self-care practices: A comparison of groups at different risk for cancers
|
2010/2011 |
| 2 |
|
09080682
|
566624 |
Application of COLD-PCR sequencing for the early detection of HBV antiviral drug resistant mutations
|
2008/2009 |
| 3 |
|
08070852
|
583052 |
Identification of hepatitis B virus DNA polymerase sequences to predict virological response to entecavir therapy
|
2008/2009 |
| 4 |
|
05060741
|
400209 |
Health-related quality of life and health preference of patients with chronic Hepatitis B infections
|
2006/2007 |
| 5 |
|
06060572
|
800000 |
Hepatitis B virus array for genotyping and mutation detection
|
2006/2007 |
| 6 |
|
|
678715 |
A phase II, open-label, multinational, multi-centre, sequential group, dose-escalation study to assess the safety and antiviral activity of LB80380 for 24 weeks in patients with chronic hepatitis B who have developed lamivudine-resistant (YMDD mutant) HBV
|
2003/2004 |
| 7 |
|
01030421
|
359654 |
Hepatitis B or Hepatitis C viral infection and genotypes - which subgroup is more prone to the development of hepatocellular carcinoma? A systematic review
|
2003/2004 |
| 8 |
|
|
146305 |
A randomized, double-blind trial of Telbivudine (LdT) versus Lamivudine in adults with decompensated chronic hepatitis B and evidence of cirrhosis
|
2003/2004 |
| 9 |
|
|
334152 |
Long-term assessment of treatment outcomes with entecavir and lamivudine for chronic hepatitis B infection in patients who have enrolled in phase iii entecavir trials
|
2002/2003 |
| 10 |
|
|
294276 |
A phase I/II dose escalation study to evaluate the pharmacokinetics, safety, and antiviral activity of beta-L-2'-Deoxycytidine-3'-monovaline ester (monoval-LdC) in adults with chronic hepatitis B
|
2002/2003 |
| 11 |
|
|
980359 |
A phase IIb extension study of LdT (Telbivudine), lamivudine, or LdT plus lamivudine in patients with chronic hepatitis B who have completed study NV-02B-003
|
2002/2003 |
| 12 |
|
|
627204 |
A preliminary assessment of safety and antiviral activity of open-label entecavir plus lamivudine therapy in subjects with chronic hepatitis B who have viremia on monotherapy in other entecavir trials
|
2002/2003 |
| 13 |
|
|
49989 |
A phase III study of the comparison of entecavir to lamivudine in chronic hepatitis B subjects with incomplete response to current lamivudine therapy
|
2001/2002 |
| 14 |
|
|
957263 |
A phase III study of the safety and antiviral activity of entecavir vs lamivudine in adults with chronic hepatitis B infection who are positive for hepatitis B e antigen
|
2000/2001 |
|
